Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

ClinicalTrials.gov ID: NCT00195715

Public ClinicalTrials.gov record NCT00195715. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi Center, Open Label Study of the Human Anti TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Crohn's Disease

Study identification

NCT ID
NCT00195715
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
777 participants

Conditions and interventions

Interventions

  • Adalimumab Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2004
Primary completion
Feb 28, 2006
Completion
Nov 30, 2008
Last update posted
Jul 11, 2011

2004 – 2008

United States locations

U.S. sites
63
U.S. states
28
U.S. cities
59
Facility City State ZIP Site status
Site Ref # / Investigator 1894 Huntsville Alabama 35801
Site Ref # / Investigator 1895 Jacksonville Alabama 35801
Site Ref # / Investigator 1787 La Jolla California 92037
Site Ref # / Investigator 1902 Roseville California 95661
Site Ref # / Investigator 1824 San Diego California 92123
Site Ref # / Investigator 1891 San Diego California 92123
Site Ref # / Investigator 1860 Englewood Colorado 80113
Site Ref # / Investigator 6178 Lone Tree Colorado 80124
Site Ref # / Investigator 1904 Wheat Ridge Colorado 80033
Site Ref # / Investigator 1858 Bridgeport Connecticut 06606
Site Ref # / Investigator 1827 Clearwater Florida 33765
Site Ref # / Investigator 1883 Gainesville Florida 32610
Site Ref # / Investigator 1909 Hollywood Florida 33021
Site Ref # / Investigator 1884 Ormond Beach Florida 32174
Site Ref # / Investigator 1786 Winter Park Florida 32789
Site Ref # / Investigator 1912 Atlanta Georgia 30342
Site Ref # / Investigator 1878 Arlington Heights Illinois 60005
Site Ref # / Investigator 2534 Chicago Illinois 60637
Site Ref # / Investigator 1823 Peoria Illinois 61602
Site Ref # / Investigator 1885 Anderson Indiana 46016
Site Ref # / Investigator 1900 Indianapolis Indiana 46202
Site Ref # / Investigator 1890 Indianapolis Indiana 46237
Site Ref # / Investigator 1892 Lexington Kentucky 40536
Site Ref # / Investigator 1906 Metairie Louisiana 70006
Site Ref # / Investigator 1881 Annapolis Maryland 24101
Site Ref # / Investigator 1829 Chevy Chase Maryland 20815
Site Ref # / Investigator 1782 Lutherville Maryland 21093
Site Ref # / Investigator 1887 Silver Spring Maryland 20901
Site Ref # / Investigator 2602 Worcester Massachusetts 01610
Site Ref # / Investigator 1773 Plymouth Minnesota 55446
Site Ref # / Investigator 1856 Rochester Minnesota 55905
Site Ref # / Investigator 1832 Jackson Mississippi 39202
Site Ref # / Investigator 1880 Kansas City Missouri 64131
Site Ref # / Investigator 1853 Mexico Missouri 65265
Site Ref # / Investigator 1888 St Louis Missouri 63110
Site Ref # / Investigator 1862 St Louis Missouri 63128
Site Ref # / Investigator 1901 Egg Harbor New Jersey 08234
Site Ref # / Investigator 1825 Great Neck New York 11021
Site Ref # / Investigator 1848 Lake Success New York 11042
Site Ref # / Investigator 1841 New York New York 10028
Site Ref # / Investigator 1852 Asheville North Carolina 28801
Site Ref # / Investigator 1882 Charlote North Carolina 28211
Site Ref # / Investigator 1855 Charlotte North Carolina 28207
Site Ref # / Investigator 1911 Raleigh North Carolina 27612
Site Ref # / Investigator 1861 Wilmington North Carolina 28403
Site Ref # / Investigator 1784 Beachwood Ohio 44122
Site Ref # / Investigator 1896 Beavercreek Ohio 45440
Site Ref # / Investigator 1833 Cincinnati Ohio 45219
Site Ref # / Investigator 1826 Cleveland Ohio 44106-5066
Site Ref # / Investigator 1822 Portland Oregon 97220
Site Ref # / Investigator 1886 Pittsburgh Pennsylvania 15216
Site Ref # / Investigator 1905 Columbia South Carolina 29204
Site Ref # / Investigator 1769 Germantown Tennessee 38138
Site Ref # / Investigator 1907 Nashville Tennessee 37205
Site Ref # / Investigator 1963 Nashville Tennessee 37232
Site Ref # / Investigator 1899 Round Rock Texas 78681
Site Ref # / Investigator 1903 Salt Lake City Utah 84107
Site Ref # / Investigator 6180 Charlottesville Virginia 22911
Site Ref # / Investigator 1783 Danville Virginia 24541
Site Ref # / Investigator 1897 Norfolk Virginia 23502
Site Ref # / Investigator 1850 Spokane Washington 99204
Site Ref # / Investigator 1831 Milwaukee Wisconsin 53215
Site Ref # / Investigator 1849 West Bend Wisconsin 53095

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00195715, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00195715 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →